Review
doi: 10.1097/00006982-200512001-00054.
Hurdles and opportunities for a venture capitalist investing in therapies for orphan retinal diseases
Affiliations
- PMID: 16374312
- DOI: 10.1097/00006982-200512001-00054
Item in Clipboard
Review
Hurdles and opportunities for a venture capitalist investing in therapies for orphan retinal diseases
Retina.
2005 Dec.
No abstract available
Similar articles
-
Convincing a venture capitalist to invest in your idea.Nat Biotechnol. 2003 Jul;21 Suppl:BE45-8. Nat Biotechnol. 2003. PMID: 12874980 No abstract available.
-
Filters for preparing to meet a venture capitalist.Nat Biotechnol. 2003 Jul;21 Suppl:BE49-50. Nat Biotechnol. 2003. PMID: 12874981 No abstract available.
-
The rise of European venture capital for biotechnology.Nat Biotechnol. 2003 Nov;21(11):1287-91. doi: 10.1038/nbt1103-1287. Nat Biotechnol. 2003. PMID: 14595356 No abstract available.
-
Challenges in genetic testing for clinical trials of inherited and orphan retinal diseases.Retina. 2005 Dec;25(8 Suppl):S72-S73. doi: 10.1097/00006982-200512001-00034. Retina. 2005. PMID: 16374347 Review. No abstract available.
-
Challenges associated with clinical trials for inherited and orphan retinal diseases.Retina. 2005 Dec;25(8 Suppl):S10-S12. doi: 10.1097/00006982-200512001-00004. Retina. 2005. PMID: 16374308 Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
